Search results for "FDA update"
First drug in new class approved
The FDA recently approved canaglifozin (Invokana) tablets to improve glycemic control in adults with type 2 diabetes, along with diet and exercise.
https://diabetes.acponline.org/archives/2013/06/14/10.htm
14 Jun 2013
New long-acting insulin drugs approved
Insulin degludec injection (Tresiba) and insulin degludec/insulin aspart injection (Ryzodeg 70/30) were approved by the FDA on Sept. 25.
https://diabetes.acponline.org/archives/2015/10/09/8.htm
9 Oct 2015
Glucose monitoring system approved specifically for critical care units
The FDA recently approved a new indication for the Nova StatStrip Glucose Hospital Meter System, extending its use to critically ill patients who have been hospitalized.
https://diabetes.acponline.org/archives/2014/11/14/7.htm
14 Nov 2014
Single and combo diabetes drugs approved
Alogliptin (Nesina) and two new combination drugs (alogliptin and metformin hydrochloride [Kazano] and alogliptin and pioglitazone [Oseni]) were approved by the FDA to improve blood glucose control in adults with type 2 diabetes, along with diet and exercise.
https://diabetes.acponline.org/archives/2013/05/10/12.htm
10 May 2013
Another weight loss drug approved
A combination of phentermine and topiramate extended-release (Qsymia) was recently approved by the FDA as an addition to a reduced-calorie diet and exercise for chronic weight management.
https://diabetes.acponline.org/archives/2012/10/12/10.htm
12 Oct 2012
New contraindication for aliskiren-containing medications
Aliskiren-containing medications are contraindicated with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with diabetes.
https://diabetes.acponline.org/archives/2012/07/13/10.htm
13 Jul 2012
Glucose monitoring app, weight-loss device, medications approved
The FDA approved an app for continuous glucose monitoring, a weight-loss device, a combination diabetes pill, and a new indication for an eye medication in the past month.
https://diabetes.acponline.org/archives/2015/02/13/7.htm
13 Feb 2015
Aflibercept approved for diabetic retinopathy in diabetic macular edema
Aflibercept (Eylea) has received expanded approval to treat diabetic retinopathy (DR) in patients with diabetic macular edema (DME), the FDA recently announced.
https://diabetes.acponline.org/archives/2015/04/10/7.htm
10 Apr 2015
Alert warns about cybersecurity risk with insulin pump system
A potential issue with the Medtronic MiniMed 600 Series Insulin Pump System's communication protocol could allow unauthorized access to the device, the FDA said.
https://diabetes.acponline.org/archives/2022/10/14/9.htm
14 Oct 2022
New drug approved, meters recalled
Dapaglifozin (Farxiga), a new medication to treat type 2 diabetes, was recently approved by the FDA for use along with diet and exercise.
https://diabetes.acponline.org/archives/2014/03/14/7.htm
14 Mar 2014